Form 4 for BMY Bristol Myers Squibb
Accepted 2021-12-06 00:00:00 ET · period of report 2021-12-02 · accession 0000014272-21-000232 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-12-06 | 2021-12-02 | BMY | VESSEY RUPERT | EVP, Research, Early Dev | M - OptEx | $0.00 | +8,792 | 55.8K | +19% | $0 |
| D | 2021-12-06 | 2021-12-02 | BMY | VESSEY RUPERT | EVP, Research, Early Dev | F - Tax | $55.41 | -4,498 | 51.3K | -8% | -$249.2K |
| D | 2021-12-06 | 2021-12-02 | BMY | VESSEY RUPERT | EVP, Research, Early Dev | M - OptEx | $0.00 | -8,792 | 17.6K | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, $0.10 par value | 2021-12-02 | M | A | 8,792 | $0.00 | 55,756 | D | — | — | (F1) The restricted stock unit vests in four equal annual installments beginning on December 2, 2020. |
| 2 | Common | Common Stock, $0.10 par value | 2021-12-02 | F | D | 4,498 | $55.41 | 51,258 | D | — | — | (F2) Shares withheld for payment of taxes upon vesting of awards. |
| 3 | Derivative | Restricted Stock Units | 2021-12-02 | M | D | 8,792 | $0.00 | 17,584 | D | — · — to 2023-12-02 | 8,792 Common Stock, $0.10 par value | (F4) Each restricted stock unit converts into one share of common stock upon vesting. (F1) The restricted stock unit vests in four equal annual installments beginning on December 2, 2020. |